Answers are grounded in this paper and cite their sources.
Network meta-analysis evaluates treatment effects on joint destruction in rheumatoid arthritis, suggesting better outcomes with certain drugs.
Our study confirms that the present routine csDMARDs, methotrexate, leflunomide, and sulfasalazine, have inhibitory effects more favourable than placebo on joint destruction in RA.
No takes yet. Share an insight, caveat, or question.
Guski et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: